The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study.

American heart journal

Volumn 147, Issue 2, 2004, Pages

  Kozàkovà, Michaela ^a   Marco, Jean ^a   Heusch, Gerd ^a   Bernies, Monique ^a   Bossi, Irene M ^a   Palombo, Carlo ^a   Anguissola, Gian Battista ^a   Donatelli, Francesco ^a   Laurent, Jean Pierre ^a   Gregorini, Luisa ^a  

^a CLINIQUE PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; URAPIDIL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PIPERAZINES; STENTS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1642361824     PISSN: None     EISSN: 10976744     Source Type: Journal    
DOI: None     Document Type: Article

References (0)